相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma
Li Liu et al.
BJU INTERNATIONAL (2016)
European Association of Urology Guidelines for Clear Cell Renal Cancers That Are Resistant to Vascular Endothelial Growth Factor Receptor-Targeted Therapy
Thomas Powles et al.
EUROPEAN UROLOGY (2016)
Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy
Thomas Powles et al.
EUROPEAN UROLOGY (2016)
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers
Xiaohui Yan et al.
CANCER CELL (2015)
miR-200c Targets CDK2 and Suppresses Tumorigenesis in Renal Cell Carcinoma
Xuegang Wang et al.
MOLECULAR CANCER RESEARCH (2015)
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
Daniel Zingg et al.
NATURE COMMUNICATIONS (2015)
HOTAIR enhanced aggressive biological behaviors and induced radio-resistance via inhibiting p21 in cervical cancer
Li Jing et al.
TUMOR BIOLOGY (2015)
LncRNA: A link between RNA and cancer
Guodong Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development
Iawen Hsu et al.
CARCINOGENESIS (2014)
Long Non-coding RNA HOTAIR Is Targeted and Regulated by miR-141 in Human Cancer Cells
Takeshi Chiyomaru et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer
Jun Qin et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Functional interactions among microRNAs and long noncoding RNAs
Je-Hyun Yoon et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
S. Hibino et al.
ONCOGENESIS (2014)
Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation
Reena V. Kartha et al.
FRONTIERS IN GENETICS (2014)
Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer
Kristina P. Sorensen et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER-CXCL12-CXCR4 signaling axis
Julie M. Hall et al.
MOLECULAR CARCINOGENESIS (2013)
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Hui Ling et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Genistein inhibits estradiol- and environmental endocrine disruptor-induced growth effects on neuroblastoma cells in vitro
Jicui Zheng et al.
ONCOLOGY LETTERS (2013)
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner
Jason Gertz et al.
GENOME RESEARCH (2012)
Targeting the vasculature of visceral tumors: novel insights and treatment perspectives
L. V. Klotz et al.
LANGENBECKS ARCHIVES OF SURGERY (2012)
Long non-coding RNAs and cancer: a new frontier of translational research?
R. Spizzo et al.
ONCOGENE (2012)
Expression of EZH2 in renal cell carcinoma as a novel prognostic marker
Hye Won Lee et al.
PATHOLOGY INTERNATIONAL (2012)
Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Chromatin Modification and Is Associated with Poor Prognosis in Colorectal Cancers
Ryunosuke Kogo et al.
CANCER RESEARCH (2011)
Tumor Biology and Prognostic Factors in Renal Cell Carcinoma
David S. Finley et al.
ONCOLOGIST (2011)
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Nina Wagener et al.
BMC CANCER (2010)
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta et al.
NATURE (2010)
Epidemiology and risk factors for kidney cancer
Wong-Ho Chow et al.
NATURE REVIEWS UROLOGY (2010)
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
Loukas F. Kontovinis et al.
BMC CANCER (2009)
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages
Yuanjie Niu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Androgen receptor is a tumor suppressor and proliferator in prostate cancer
Yuanjie Niu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
miRBase: tools for microRNA genomics
Sam Griffiths-Jones et al.
NUCLEIC ACIDS RESEARCH (2008)
Estrogen receptor beta (ERβ) protein expression correlates with BAG-1 and prognosis in brain glial tumours
Anna Batistatou et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G(2) cell cycle arrest
S Paruthiyil et al.
CANCER RESEARCH (2004)
Differential expression of estrogen receptor β (ERβ) and its C-terminal truncated splice variant ERβcx as prognostic predictors in human prostatic cancer
T Fujimura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Soya intake and plasma concentrations of daidzein and genistein: validity of dietary assessment among eighty British women (Oxford arm of the European Prospective Investigation into Cancer and Nutrition)
PK Verkasalo et al.
BRITISH JOURNAL OF NUTRITION (2001)
分享论文
